Regenerative therapies for bone and cartilage injuries are currently unable to replicate the complex microenvironment of native tissue. There are many tissue engineering approaches attempting to address this issue through the use of synthetic materials. Although synthetic materials can be modified to simulate the mechanical and biochemical properties of the cell microenvironment, they do not mimic in full the multitude of interactions that take place within tissue. Decellularized extracellular matrix (dECM) has been established as a biomaterial that preserves a tissue's native environment, promotes cell proliferation, and provides cues for cell differentiation. The potential of dECM as a therapeutic agent is rising, but there are many limitations of dECM restricting its use. This review discusses the recent progress in the utilization of bone and cartilage dECM through applications as scaffolds, particles, and supplementary factors in bone and cartilage tissue engineering.
| INTRODUCTION
Regenerative medicine offers the ability to repair injuries that the body fails to heal. Although there are many synthetically designed materials to support tissue regeneration, these materials fall short of fully replicating a tissue's microenvironment. 1 Looking to the function of this microenvironment for inspiration has provided insight into how materials used in tissue regeneration can be improved. One potential therapeutic material is the native extracellular matrix (ECM), which is the noncellular component of tissue that provides the structural support and biochemical cues for determining a cell's fate. 2 ECM is a natural material that encompasses both the cell microenvironment and biochemical factors for living cells. 3, 4 Each tissue type has a specialized ECM structure and composition that modulates cell responses and benefits the survival of cells within that tissue. 2 ECM is composed of two major components, collagen and proteoglycans, which are secreted by cells and assembled in a manner specific to individual tissue types. It contains a reservoir of growth factors and cytokines; these send signals that regulate cell proliferation and migration as well as modulate differentiation and phenotypic expression of the cell. Due to its inherent compositional similarity and modulatory abilities of supporting tissue growth and differentiation, the use of tissuespecific ECM for tissue regeneration has gained popularity, including in the areas of bone and cartilage engineering.
Bone ECM consists of an organic and inorganic phase. The organic phase, mostly type I collagen, provides the tissue with flexibility, while the inorganic phase, mainly consisting of calcium phosphate, specifically hydroxyapatite (HA), 5 is the source of bone strength. 6 In addition, there are four cell types in bone tissue that contribute to osteogenesis: (a) undifferentiated osteoprogenitor cells, (b) matrix- † These authors contributed equally to this study.
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eration capabilities, which is also compounded by the avascular nature of the tissue. In cases when healing does occur, it often yields the formation of fibrous cartilage, which leads to stiffer tissue at the injury site and long-term performance issues. 3, 11 To improve function, regenerative therapies promote the formation of native articular/hyaline cartilage rather than fibrous cartilage.
To process ECM for use in regenerative therapy, the excised tissue must first undergo decellularization. Decellularization refers to the process of treating a tissue with any combination of physical stress and chemical/enzymatic agents to remove cellular components, leaving behind only the noncellular ECM that can be used for therapeutic applications. The specific method of decellularization used depends on the tissue type; for instance, while cartilage tissue is able to undergo a relatively harsh treatment, lung tissue requires a more sensitive decellularization method to preserve its tissue composition. 14 The resulting decellularized extracellular matrix (dECM) can then be processed further for different tissue engineering applications. These applications are summarized in Table 1 . The main benefit of dECM is that it retains components of the natural cell environment 2 ; with proper decellularization, the complex biomolecular and physical cues in the ECM are preserved and can support cell growth and viability.
Unlike in transplanted tissue, dECM has a lower risk for immune response because almost all the cellular DNA is removed. 15 However, the decellularization process does present challenges, the foremost of which is maximizing the removal of cellular material while limiting damage to the ECM. 15 Although synthetic materials have their benefits, such as tunability of physicochemical properties, they are unable to fully replicate the native microenvironment and structure of the tissue, even with modifications or the addition of bioactive factors. 1 Thus, incorporating dECM presents a promising method for creating an environment that better mimics that of native tissue and suits repair of the injury site.
| GENERAL METHODS OF DECELLULARIZATION
To retain as much of the tissue's bioactivity as possible while maximizing the removal of nuclear material, the decellularization process must minimize the loss of native ECM components. Implantation of decellularized tissue that has had its nucleic materials incompletely removed or degraded could result in host foreign body reaction, which leads to the formation of fibrous capsule surrounding the implant site. 16, 17 This eventually can result in improper tissue remodeling and therefore limit the regenerative potential of the decellularized tissue. 18 Preserving the ECM ultrastructure is also important in applications where dECM is not further processed but used as a scaffold by itself. Specific decellularization procedures vary according to the tissue type and can involve a combination of (a) physical, (b) enzymatic, and (c) chemical processes. The most frequently used techniques are discussed below.
Physical decellularization
Introducing physical stresses such as freeze-thaw and osmotic pressure can result in cell lysis without significantly disrupting the ultrastructure of the tissue. Freeze-thawing is one of the most widely used physical decellularization methods, during which the formation of ice crystals puncture cell membranes. The cycle is repeated multiple times before the tissue sample can be processed further. Another option is osmotic lysis, during which tissues are placed in either a hypertonic 19 or hypotonic solution such as deionized water 20 that ruptures the plasma membrane via osmotic shock. Other common physical decellularization methods include hydrostatic pressure, 21 sonication, 22 and electroporation. 23 Tissues that undergo only physical decellularization, specifically freeze-thawing, are considered to be devitalized but not decellularized, as the cells have been lysed, but the cell debris and genetic material still remain within the processed tissue. These samples are most often processed into particles, during which the tissues go through a combination of freeze-thawing and lyophilization, and are then ground into powder using a freezer/mill. 19, [24] [25] [26] [27] and show characteristics of both ionic and nonionic detergents. 15 Although zwitterionic detergents result in less denaturing of proteins compared to ionic detergents, they also tend to remove less cellular material than ionic detergents.
41,42
Enzymatic decellularization
Enzymatic decellularization is most often used directly after chemical decellularization to further facilitate the cell degradation and the removal of residual nuclear material from the tissue. Nucleases and proteases are the most widely used enzymes for enzymatic decellularization. Nucleases, such as deoxyribonuclease and ribonuclease, act directly on DNA and RNA chains, respectively, to hydrolyze phosphodiester bonds. Proteases, such as trypsin, act on proteins by hydrolyzing peptide bonds. Trypsin is a serine protease that cleaves the carbonyl side of lysine or arginine residues. Because of its specific activity on peptides, trypsin treatment can severely disrupt ECM proteins such as elastin and collagen. 15 Enzymatic methods are frequently used in conjunction with chelating agents such as ethylenediaminetetraacetic acid (EDTA), which disrupt cell adhesion to ECM proteins by sequestering metallic ions such as calcium. 15 
Evaluation of the degree of decellularization
Measuring the amount of double-stranded DNA (dsDNA) in dECM is the current gold standard for evaluating the degree of successful decellularization. By comparing the amount of DNA in tissue samples before and after decellularization using quantitative assays such as PicoGreen, 43 it is possible to make general conclusions on whether the sample has been sufficiently decellularized. Crapo et al. have suggested three minimum criteria that tissues should satisfy to be considered successfully decellularized: (a) tissue samples should contain < 50 ng of dsDNA per mg of dry ECM, (b) any remaining DNA fragments should be smaller than 200 base pairs, and (c) the tissue should not have visible nuclear material when stained with DAPI or hematoxylin & eosin. 15 In addition to quantifying the remaining cellular material, it is also important to evaluate both the macroscopic change in the ECM structure and the biochemical composition to ensure minimal disruption of the ECM composition. For applications where the whole tissue is decellularized without being further broken down into smaller particles, imaging techniques such as scanning/transmission electron microscopy 40, 44 and microcomputed tomography 45, 46 can be used to compare the structure of ECM both before and after decellularization. For more quantitative analyses, the amount of sulfated glycosaminoglycans (sGAGs) and collagen can be evaluated using dimethylmethylene blue (DMMB) 47 and hydroxyproline assays, 48 respectively. These assays are well-established and can help investigators draw more concrete conclusions about the efficacy of the decellularization protocol used.
3 | POSTDECELLULARIZATION PROCESSING METHODS
| Decellularized ECM as a scaffold
One of the simplest methods of using dECM is as a scaffold that maintains its original geometry. The biggest advantage of this method is that, compared to other processing methods that completely pulverize the dECM, using it as an unprocessed scaffold suggests that the tissue retains a large portion of its original ECM architecture. dECM can be prepared from various tissue types to accommodate different compositions, topographies, and mechanical properties. 49 However, such benefits can only be obtained if (a) most of the cell debris is removed from the tissue without destruction of essential ECM components such as GAGs and collagen fibers and (b) the dECM can be thoroughly recellularized. As a result, recent literature has focused on the effects of decellularization methods on the composition and ultrastructure of the resulting tissue and the degree of recellularization.
| Bone
The development of a decellularized bone scaffold has been motivated by the need to improve the biocompatibility of allograft bone 50 and the benefit of preserving the bone's native structure. 45 ,46 Xu et al. successfully decellularized annulus fibrosus tissue from porcine spine while maintaining its macroscopic structure. 45 Different types of decellularization methods showed various effects on the retention of ECM molecules; trypsin treatment resulted in lowest GAG content, followed by SDS and Triton X-100. All three methods did not result in significant loss of collagen. 45 Smith et al. investigated the effect of donor age on the resulting osteogenic capacity of the isolated human bone following decellularization. 46 The authors reported that bone from an old donor (≥70 years age) was more porous and less dense than that from a young donor (≤50 years age), but the tissues otherwise had similar composition (e.g.,mineral density, calcium/phosphate ratio). MSCs seeded on decellularized bones from older donors expressed higher levels of osteogenic markers than those seeded on decellularized bones from young donors, which the authors attributed to enhanced porosity. Decellularized bone has also been subjected to further modifications, such as collagen/HA coating. 51 When type I collagen solutions were applied to the surface of decellularized porcine cancellous bone, the coating modulated the stiffness of the matrix.
Higher collagen concentration led to higher matrix stiffness compared to uncoated matrices, which in turn guided more robust differentiation of seeded MSCs into osteogenic lineages. ABC during decellularization to aid the removal of GAGs from porcine articular cartilage. 60 The authors also created channels through the tissue, which was then overlaid with cell suspension and centrifuged (to pull the cells deeper into the tissue). These treatments, although successful in enhancing decellularization, did not improve recellularization rates. Tyler et al. conducted an in vivo study using the ovine osteochondral defect model, during which a decellularized osteochondral allograft was implanted and studied after 12 weeks. 61 The constructs were remodeled by infiltrating cells, but the cell density was still lower than that of healthy cartilage, resulting in a low GAG concentration within the decellularized implant.
| Cartilage
Although maintaining the native architecture during decellularization has its benefits, dECM scaffolds are limited to certain geometries and cannot easily be scaled. To circumvent this, decellularized tissue can be pulverized and freeze-dried into particles that are packed into molds, making it possible to fabricate highly porous dECM scaffolds of varying geometry. 59, [62] [63] [64] [65] Architectural attributes like the size of pores within these scaffolds can impact the behavior of seeded cells.
Almeida et al. prepared coarse and fine dECM particles by processing porcine cartilage using two different methods (homogenizer and cryomill, respectively). 59 By changing the concentration of dECM particle slurry, the authors were able to prepare scaffolds with pore sizes ranging from 32 AE12 to 65 AE20 μm. Scaffolds with larger pore sizes resulted in better cell infiltration, proliferation and higher chondrogenic activity in vitro. To maintain structural fidelity and resolution of architectural features, these scaffolds usually undergo physical crosslinking such as UV irradiation or dehydrothermal treatment (DHT). 36, 66 Gawlitta et al. prepared porous scaffolds from decellularized equine cartilage and crosslinked them via UV irradiation. 63 The scaffolds were seeded with MSCs and were subcutaneously implanted in immunocompromised rats to measure osteoinductive capacity.
MSCs within the dECM-based porous scaffolds experienced chondrogenic differentiation which allowed for enhanced endochondral bone formation. 63 The behavior of cells and physical properties of the scaffolds can be affected by different crosslinking schemes. 
| Solubilized dECM as a hydrogel
Solubilized dECM is created when dECM is further digested using pepsin, creating a homogeneous solution that can undergo thermal gelation at physiological temperature and pH. As the tissue is homogenized, solubilized dECM does not preserve either the architecture or topology of the natural ECM. One of the earliest attempts to create such tissue-derived hydrogels was made with decellularized SIS. 68 The tissue, following decellularization, was pulverized in liquid nitrogen, and the resulting powder was digested in an acidic buffer containing pepsin. Digested SIS demonstrated thermally responsive gelation by maintaining the pH and ionic strength of the solution at a physiologically relevant level and placing the solution in a mold at 37 C for 30 min to an hour.
The method of fabricating a hydrogel using solubilized dECM has remained similar over the course of its use and is as follows: (a) tissue decellularization, (b) digestion with pepsin in acidic buffer, (c) neutralization of the buffer to physiological pH/salt concentration using 10 × phosphate buffered saline (PBS) and NaOH, and (d) formation of the hydrogel by bringing the temperature to 37 C.
Although pepsin digestion is the most widely used method for solubilizing dECM, the bioactivity of pepsin-digested dECM remains controversial. 69, 70 To this end, several studies have explored the possibility of using urea to extract soluble components of dECM. 71, 72 Urea is a chaotropic agent that disrupts hydrogen bonding, resulting in the denaturation of proteins and the disruption of interactions between lipids and proteins. Urea-extracted dECM had higher concentrations of small and moderate MW proteins compared to pepsin-digested dECM, which consisted primarily of collagen chains. 71 When used as a supplement in two-dimensional/three-dimensional (3D) cell culture, urea-extracted dECM also promoted tissue-specific differentiation of MSCs. 72 Chondrogenic activity was upregulated when the ureaextracted dECM was mixed with gelatin methacrylate (GelMA) hydrogels, although the effect was short term. apy. 85 The layer of dECM provides cell adhesion sites and biochemical cues that improve cell-material interactions compared to cell adhesion onto a bare scaffold. ECM ornamentation thus primes the scaffold for better cell attachment and more robust cell growth/ proliferation. 85 This process has been demonstrated on multiple types of scaffolds, such as 3D-printed scaffolds, 4, 85, 86 electrospun scaffolds, [87] [88] [89] [90] and decellularized tissue. The ECM-ornamented scaffold showed increased bone formation compared to the same scaffold with no ECM (Figure 2a) . 4 Kumar et al. 3D printed a PCL-HA scaffold on which they seeded osteoblasts to deposit mineralized ECM. 85 The scaffold was decellularized, leaving only the mineralized ECM, then reseeded with osteoblasts. The authors observed enhanced expression of the skeletal protein actin and the adhesion protein vinculin compared to undecorated scaffolds (Figure 2b ). They also found improved cell-scaffold and cell-cell interactions, which correlate to increased cell adhesion, growth, and motility compared to bare PCL-HA scaffolds. 85 Electrospun scaffolds have also been used as templates for cell-laid ECM. 87 Aside from synthetic polymers, using decellularized SIS for ECM ornamentation has also been investigated. fold. 97, 98 Chondrocytes seeded on the dECM scaffold synthesized more GAGs and type II collagen than those seeded on atelocollagen (scaffold derived from bovine Achilles tendon fibers). A similar trend was observed in vivo, where dECM scaffold groups not only contained more GAGs, but also had a higher compressive modulus than the control group. 97 The scaffold was also used with bone marrow stimulation (BMS) technique in a rabbit model, which further enhanced the degree of tissue regeneration compared to BMS only treatment. 98 ECM ornamentation directly addresses many of the limitations of other tissue-engineered dECM applications. As cells are seeded onto prefabricated scaffolds, complex geometries and tunable mechanical, physical, and biological properties can still be achieved through processes such as 3D printing of a synthetic scaffold while still utilizing the biological cues of natural ECM. 85 It can limit or prevent the disadvantages of other techniques, such as the effect of high pressure extrusion on cells during 3D printing, the dimensional mismatch between defect site and fabricated scaffold in implantable hydrogels, and the lack of structural support in dECM alone. 4 In addition, celldirected ECM-ornamenting offers a more physiologically relevant microenvironment formation than a simple, manual coating with dECM, as coating can yield fragmented ECM components that do not accurately represent native ECM. 4 Thus, by employing ECM ornamentation, scaffolds can be fabricated from tunable synthetic materials in complex geometric and synergistically incorporate natural ECM proteins to better recapitulate the ECM environment. 4 
| Bioink
Another interesting application of dECM is its use as a 3D printable bioink. 3D printing, or additive manufacturing, is the creation of threedimensional structures layer-by-layer. The most common method of 3D printing bioinks is extrusion printing, during which the material is deposited via a mechanically controlled syringe into a desired geometry. 99 This technique is capable of creating complex architectures by depositing multiple materials with high spatial control. These complex geometries can be obtained through the design of a computer model to match a defect site identified via medical imaging modalities such as MRI or CT. 99 Bioactive molecules such as growth factors and different cell types can be incorporated into the scaffold to better mimic complex tissue architectures, such as the transition from bone to cartilage in an osteochondral defect. 100 Porosity can also be tightly controlled within 3D printed constructs to ensure adequate gas and waste exchange as well as nutrient delivery. erties of the material. 102 By utilizing two crosslinkers and two separate polymerization steps, the authors were able to fabricate a bioink that has a low enough viscosity to be printed and, following printing, increase the elastic modulus of the scaffold through a secondary polymerization step. dECM from different tissues (e.g.,liver, cardiac, skeletal) have been used with this tunable hydrogel system to formulate bioinks that replicate not only the physical but also the biological properties of the representative tissue. 102 Utilizing dECM on its own as a bioink for 3D printing is challenging due to its low viscosity and mechanical instability. 101, 103 Bulk hydrogels formed using solubilized dECM only reach stiffnesses similar to or slightly better than that of pure collagen gels 71 and have very slow gelation times, ranging from 30 minutes to an hour. 104, 105 Although increasing the weight percent of a dECM hydrogel can improve its stiffness, 106 using such methods for 3D printing is limited as the stiffness of the dECM bioink must be low enough to achieve a viscosity that enables dECM to be extruded through the needle. As such, multiple efforts have been devoted to enhancing the printability of dECM bioinks and the mechanical stability of printed scaffolds by combining them with secondary polymer frameworks, 101 mixing them with synthetic polymers, 102 and using crosslinkers. 103 For instance, adding 0.02% vitamin B2 to a 2% heart dECM bioink and UV-crosslinking the construct after each layer allowed the final construct to reach a compressive modulus of 15.74 kPa, compared to that of a non UV-crosslinked construct at 0.18 kPa. 103 For applications such as bone tissue where much higher moduli are required, dECM bioinks can be combined with 3D printed porous PCL scaffolds, which can reach compressive moduli in the MPa range. 107 In addition, there have also been efforts to develop shear-thinning hydrogels that can flow through the needle and retain their shape after they have been printed. [108] [109] [110] Such approaches may be translated into the printing of dECM to improve its printability.
| Decellularized ECM particles
Rather than being used as a standalone scaffold, dECM can be milled into particles that contain ECM components inherent to the tissue type and can provide binding sites for cells. These particles can then be combined with nonbioactive synthetic or biological scaffolds to form a composite scaffold that have tissue-specific bioactivity. This flexibility allows dECM particles to be incorporated into various types of scaffolds, such as (a) hydrogels, (b) electrospun scaffolds, and (c) 3D-printed scaffolds. crosslinked dECM particles with modified GAGs (chondroitin sulfate, hyaluronic acid) via carbodiimide chemistry. 113 Constructs containing bone dECM particles enhanced in vivo bone formation when compared to hydrogels that did not contain dECM particles.
| Electrospun scaffolds
dECM particles can be incorporated into electrospun scaffolds either during 27 or after electrospinning. 114 Garrigues et al. dissolved dECM particles in isopropanol and added PCL to increase the solution's viscosity for electrospinning. 27 The resulting dECM-containing electrospun scaffolds showed higher sGAG content and increased collagen synthesis activity from seeded ADSCs compared to PCL scaffolds. ADSCs seeded on 3D-printed PCL scaffolds incorporating bone dECM particles. 122 The authors observed enhanced bone deposition and increased expression of osteogenic genes such as osteonectin compared to PCL scaffolds containing nonbiological components commonly used to promote osteogenesis such as HA or TCP. This change in cellular response was attributed to the presence of collagen, as well as the natural apatite structure in dECM particles. 122 
| Particle aggregates
Cell-seeded dECM particles can be delivered into the defect site as a particle aggregate. 123, 124 Yin et al. generated dECM particles from goat articular cartilage. These dECM particles were then seeded with
MSCs and aggregated in a rotary cell culture system. 123 Teng et al. cultured cartilage-like tissue by culturing chondrocyte spheroids in suspension in vitro, which were subsequently decellularized and milled into particles. 124 In both cases, dECM particles not only induced chondrogenic behavior from seeded MSCs in vitro, but the MSC/particle aggregate also promoted osteochondral defect repair in vivo.
| SUMMARY AND FUTURE PERSPECTIVES
Decellularized ECM is a tissue-derived biomaterial that can be used as a bioactive component for tissue engineering applications. The versatility of dECM allows it to be processed for various applications, from a whole tissue scaffold to a digested solution that could be used as a General decellularization guidelines that could widely be agreed upon by investigators will pave the way for a more standardized field of tissue decellularization. In addition, the development of methods to enhance the physicochemical properties of dECM while harnessing its native regenerative capacities will be the key to providing viable therapeutic applications for bone and cartilage tissue regeneration.
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